About Suven Life Sciences
Suven Life Sciences is a company based in Hyderabad (India) founded in 1989. The company has 187 employees as of March 31, 2024. Suven Life Sciences has completed 2 acquisitions, including Asian Clinical Trials and Rising Pharmaceuticals. Suven Life Sciences offers products and services including Drug Discovery Services, Masupirdine, Samelisant, and Analytical Chemistry Services.
- Headquarter Hyderabad, India
- Employees 187 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Suven Life Sciences Limited
-
Annual Revenue
$779.08 K (USD)-43.08as on Mar 31, 2025
-
Net Profit
-$18.85 M (USD)-52.98as on Mar 31, 2025
-
EBITDA
-$19.31 M (USD)-29.45as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
187
as on Mar 31, 2024
-
Investments & Acquisitions
Asian Clinical Trials
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Suven Life Sciences
Suven Life Sciences is a publicly listed company on the NSE with ticker symbol SUVEN in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Suven Life Sciences
Suven Life Sciences offers a comprehensive portfolio of products and services, including Drug Discovery Services, Masupirdine, Samelisant, and Analytical Chemistry Services.
Offers synthetic and medicinal chemistry for drug development.
Targets cognitive deficits in Alzheimer's disease.
Addresses narcolepsy and cognitive disorders.
Provides testing for drug discovery processes.
People of Suven Life Sciences
Unlock access to complete
Unlock access to complete
Funding Insights of Suven Life Sciences
Detailed funding history for Suven Life Sciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Suven Life Sciences
Suven Life Sciences has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Asian Clinical Trials and Rising Pharmaceuticals.
Investment portfolio details for Suven Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Full-service CRO for Phase I-IV clinical trials is offered.
|
Locked | Locked | 2001 | Locked | |
|
Generic and specialty pharmaceuticals are manufactured in various dosage forms.
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Suven Life Sciences
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Suven Life Sciences
Detailed financials for Suven Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Suven Life Sciences Comparisons
Peer comparison for Suven Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Suven Life Sciences
Detailed competitors of Suven Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Suven Life Sciences
Complete news archive for Suven Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suven Life Sciences
Suven Life Sciences was founded in 1989.
Suven Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2024, the latest employee count at Suven Life Sciences is 187.
Annual revenue of Suven Life Sciences is $779.08K as on Mar 31, 2025.
Suven Life Sciences offers a suite of services that include CRAMS, drug discovery (includes internal discovery with their own pipeline) and development support services (DDDSS) and formulation development manufacturing services (FDC) for small molecules. They offer a full range of services in drug discovery, development, and manufacturing. Through their CRAMS services, they offer medicinal chemistry services (Lead optimization, Intermediates Building blocks), preclinical and clinical development support, (custom synthesis, scale-up from g to kg etc.,) and API, intermediate and formulation manufacturing services. They claim to have partnerships with 60 innovator pharma companies for CRAMS initiatives and have completed 600 projects. As part of their DDDSS, they offer bioanalytical services (BABE, SADMAD, toxicology studies etc.), PKPD and ADME services. As part of their FDC services they offer analytical method development validation, stability studies etc., Their facilities have been approved for API and intermediate production by the FDA (formulations also), EDQM, MHRA, and PMDA. The company has a CNS drug discovery collaboration with Eli Lilly. Suven has 11 drugs with out-licensing potential. Suven claims to have partnerships with 61 innovator pharma companies for CRAMS initiatives. The company has 41 product patents and 15 process patents as of Jun-2016 in both developed and developing countries.
Suven Life Sciences offers Drug Discovery Services, Masupirdine, Samelisant, and Analytical Chemistry Services.
Yes, Suven Life Sciences is publicly traded on NSE under the ticker symbol SUVEN.
Suven Life Sciences has made 2 acquisitions, including Asian Clinical Trials, and Rising Pharmaceuticals.
The ticker symbol of Suven Life Sciences is SUVEN on NSE.